Europe Intra-Articular Injection for Osteoarticular Infiltrations Market 2031
预计到 2031 年,欧洲骨关节浸润关节内注射市场规模将从 2023 年的 9,743 万美元增至 1.5708 亿美元。预计 2023-2031 年市场复合年增长率为 6.2%。临床试验数量的增加预计将促进创新产品的开发,这些产品在预测期内可能会成为市场趋势。
欧洲骨关节浸润关节内注射市场分析
老年人口中骨关节炎和其他骨科疾病的发病率不断上升,注射技术也不断进步,这些都是推动市场增长的因素。此外,新配方的推出、人们对关节健康和关节内注射益处的认识不断提高,以及欧洲医疗支出的增加使得人们能够更好地获得包括关节内注射在内的先进治疗方案,这些都可能在未来几年推动欧洲骨关节浸润关节内注射市场的增长。
欧洲骨关节浸润关节内注射市场概况
骨关节炎是一种炎症性退行性疾病,其特征是关节软骨和骨下组织退化,主要影响髋关节和膝关节。骨关节炎在老年人群中的患病率不断上升,对有效治疗的需求不断增长,医护人员和患者对胶原蛋白注射益处的认识不断提高,这些因素推动了关节内注射的需求,从而有利于市场增长。透明质酸注射疗法的最新进展显著扩大了增长轨迹,例如丹麦 Nordic Medical Solutions ApS 销售的新型透明质酸 Durolane 配方改善了患者的治疗效果,并在临床中得到广泛采用。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
欧洲骨关节浸润关节内注射市场:
复合年增长率(2023 - 2031)6.2%- 2023 年市场规模
9,743 万美元 - 市场规模 2031
1.5708 亿美元
市场动态
- 骨关节炎患病率上升
- 注射技术的进步
- 骨关节浸润关节内注射的战略举措
关键人物
- Bioventus公司
- 生化学株式会社
- Maxigen生物科技公司
- 斯特姆医疗公司
- 赛诺菲公司
- 辉凌制药
- Fidia Pharma 美国公司
- 生物科技医疗集团
- 比奥泰克公司
- 医学
区域概况
- 欧洲
市场细分
- 1 型胶原蛋白
- 透明质酸
- 医院
- 骨科诊所
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
欧洲骨关节浸润关节内注射市场驱动因素和机遇
骨关节炎患病率上升有利于市场增长
全球有超过5亿人患有骨关节炎(OA),占世界人口的7%,其中法国患者超过1000万。根据美国疾病控制与预防中心(CDC)的报告,OA是导致长期残疾的主要原因,在运动员和关节受伤或创伤的人群中高发,女性患者也较多,占全球报告病例的60%。根据世界卫生组织(WHO)的报告,老年人群是OA的高发人群。虽然任何人都可能患上OA,但40岁以上的成年人最容易患上OA。Versus Arthritis 2024报告估计,英国有超过1000万人患有OA,其中540万人患有膝关节OA,320万人患有髋关节OA。此外,根据 2024 年出版的《骨关节炎和软骨开放期刊》的数据,德国约有 500 万名成年膝关节 OA 患者,患病率以 7% 的速度增长。因此,随着 OA 患病率的上升,关节内注射等新疗法在欧洲越来越受到关注。
市场参与者在骨关节浸润关节内注射方面的战略举措
关节内注射对于治疗因受伤或骨关节炎引起的关节炎症具有巨大的潜力。以下是市场参与者最近的一些战略举措。
- 2024 年 5 月,VSY Biotechnology 宣布 Re-Cross 在全球上市,其整个关节内 HA 产品组合均获得“Play Sure 不含兴奋剂认证”。该产品专为运动医学中的疼痛管理和损伤相关炎症及骨关节炎疾病的治疗而设计。
- 2023 年 9 月,KiOmed Pharma 与 Arsylab 建立战略合作伙伴关系,在法国推广和分销 Kiomedine one,这是一种用于治疗难治性膝关节骨关节炎的新型药物。通过这种合作,KiOmed Pharma 可以提供广泛的骨关节炎治疗产品,从而增强其在市场上的地位。
- Contura International Ltd 于 2021 年 9 月 21 日至 24 日在英国举行的英国骨科协会 (BOA) 年度大会上推出了一种用于治疗膝关节骨关节炎的新型水凝胶注射剂,可帮助患者无需手术即可恢复活动能力。这种新型水凝胶注射剂采用不可生物降解的水凝胶技术——Arthrosamid。
因此,随着合作与伙伴关系的增加,关节内注射治疗骨关节浸润的不断发展,预计将在未来几年为欧洲关节内注射治疗骨关节浸润市场带来巨大的增长机会。
欧洲骨关节浸润关节内注射市场报告细分分析
有助于得出欧洲骨关节浸润关节内注射市场分析的关键部分是类型和最终用户。
- 根据类型,欧洲骨关节浸润关节内注射市场分为 1 型胶原蛋白和透明质酸。1 型胶原蛋白细分市场进一步细分为聚合型、水解型和去端胶原蛋白类型。透明质酸细分市场在 2023 年占据了更大的市场份额。
- 根据最终用户,欧洲骨关节内注射市场分为医院、骨科诊所和其他。医院部门在 2023 年占据市场主导地位。预计骨科诊所部门在 2023-2031 年期间的复合年增长率最高。
欧洲骨关节浸润关节内注射市场份额(按国家)分析
欧洲骨关节浸润关节内注射市场报告的范围主要分为德国、英国、法国、意大利、西班牙、丹麦和欧洲其他地区。德国在 2023 年占据了相当大的市场份额。市场的增长是由不断增长的老龄人口、不断增加的研发活动以及关节内注射的进步推动的。人口老龄化是导致该国对治疗骨关节疾病的关节内注射需求增加的主要原因。下肢(臀部和膝盖)的骨关节炎比上肢导致更多的活动能力丧失。这些疾病可以通过膝关节透明质酸注射治疗来管理和治疗;因此,它具有巨大的增长潜力,并为服务于该市场的参与者提供了有益的机会。此外,提供关节内注射治疗和进行临床试验的各种参与者的存在有利于德国市场的增长。
欧洲骨关节浸润关节内注射市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 9,743万美元 |
2031 年市场规模 | 1.5708亿美元 |
全球复合年增长率(2023 - 2031) | 6.2% |
史料 | 2021-2022 |
预测期 | 2023-2031 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 欧洲
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
欧洲骨关节浸润关节内注射市场新闻和最新发展
通过收集一级和二级研究后的定性和定量数据来评估欧洲骨关节浸润关节内注射市场,其中包括重要的公司出版物、协会数据和数据库。欧洲骨关节浸润关节内注射市场的一些发展情况如下:
- Maxigen Biotech Inc. (MBI) 与土耳其最大的医药产品分销商之一 Mars Medicine Sağlık Ürünleri Limited Şirketi 签署了独家分销协议,成为 Maxigen Biotech 在开拓土耳其市场的长期战略合作伙伴。此次合作旨在通过供应 MBI 的产品为土耳其的医疗机构提供最佳的关节内注射技术,为患者提供全方位的膝关节治疗解决方案。由于土耳其位于中东和欧洲之间的关键位置,此次联盟将加速 MBI 在这些市场的扩张。(来源:Maxigen Biotech Inc.,新闻稿,2022 年 11 月)
- Contura Orthopaedics Ltd 与意大利领先的独立医疗器械分销商之一 Horizon Lab Company 合作,在欧洲推动患者获得其独特的治疗方法 Arthrosamid。(来源:Contura Orthopaedics Ltd,新闻稿,2022 年 6 月)
欧洲骨关节浸润关节内注射市场报告覆盖范围和交付成果
“欧洲骨关节浸润关节内注射市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:
- 欧洲骨关节浸润关节内注射市场规模以及区域和国家层面所有关键细分市场的预测
- 欧洲骨关节浸润关节内注射市场趋势,以及驱动因素、限制因素和关键机会等市场动态
- 详细的 PEST 和 SWOT 分析
- 欧洲骨关节浸润关节内注射市场分析,涵盖关键市场趋势、区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及欧洲骨关节浸润关节内注射市场的最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The rising prevalence of osteoarthritis and advancements in injection techniques are the most influential factors responsible for the market growth.
The Europe intra-articular injection for osteoarticular infiltrations market is estimated to register a CAGR of 6.2% from 2023 to 2031.
The value of the Europe intra-articular injection for osteoarticular infiltrations market is estimated to reach US$ 157.08 million by 2031.
Bioventus Inc., SEIKAGAKU CORPORATION, Maxigen Biotech Inc., İstem Medical Inc., Sanofi SA, Ferring Pharmaceuticals, Fidia Pharma USA Inc., Biotech Healthcare Group, Bioteck S.p.A., and I+MED are among the key market players in the Europe intra-articular injection for osteoarticular infiltrations market.
The List of Companies - Europe Intra-Articular Injection For Osteoarticular Infiltrations Market
- Bioventus Inc.
- SEIKAGAKU CORPORATION
- Maxigen Biotech Inc.
- Istem Medical Inc.
- Sanofi SA
- Ferring Pharmaceuticals
- Fidia Pharma USA Inc.
- Biotech Healthcare Group
- Bioteck S.p.A.
- I+MED.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.